OREGON PUBLIC EMPLOYEES RETIREMENT FUND - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OREGON PUBLIC EMPLOYEES RETIREMENT FUND ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$520,469
-22.7%
11,317
-3.4%
0.01%
-12.5%
Q2 2023$673,376
+48.2%
11,717
-3.3%
0.01%
+33.3%
Q1 2023$454,388
+29.2%
12,117
-3.4%
0.01%
+20.0%
Q4 2022$351,567
+0.7%
12,547
+1.1%
0.01%0.0%
Q3 2022$349,000
-18.8%
12,414
+0.4%
0.01%
-28.6%
Q2 2022$430,000
-13.0%
12,360
-10.2%
0.01%
+40.0%
Q1 2022$494,000
+49.7%
13,760
-2.8%
0.01%
+25.0%
Q4 2021$330,000
+17.4%
14,160
-4.1%
0.00%
+33.3%
Q3 2021$281,000
-6.3%
14,760
-0.7%
0.00%0.0%
Q2 2021$300,000
+10.3%
14,8600.0%0.00%0.0%
Q1 2021$272,000
-7.2%
14,860
+2.1%
0.00%
-25.0%
Q4 2020$293,000
+5.8%
14,560
-1.6%
0.00%0.0%
Q3 2020$277,000
-10.6%
14,790
+7.3%
0.00%
-20.0%
Q2 2020$310,000
+51.2%
13,7900.0%0.01%
+25.0%
Q1 2020$205,000
-22.9%
13,7900.0%0.00%0.0%
Q4 2019$266,000
-2.6%
13,7900.0%0.00%0.0%
Q3 2019$273,000
-4.9%
13,790
+1.5%
0.00%0.0%
Q2 2019$287,000
+4.7%
13,590
+1.5%
0.00%0.0%
Q1 2019$274,000
+4.6%
13,390
+1.8%
0.00%0.0%
Q4 2018$262,00013,1480.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Campbell & CO Investment Adviser LLC 11,961$219,0000.13%
FEDERATED HERMES, INC. 3,441,367$63,046,0000.12%
CORNERCAP INVESTMENT COUNSEL INC 54,751$1,003,0000.11%
GSA CAPITAL PARTNERS LLP 34,425$631,0000.10%
First Trust Direct Indexing L.P. 11,913$218,0000.06%
Summit Global Investments 47,546$871,0000.06%
WINTON GROUP Ltd 49,766$912,0000.05%
FULLER & THALER ASSET MANAGEMENT, INC. 397,950$7,290,0000.05%
AIGEN INVESTMENT MANAGEMENT, LP 16,077$295,0000.04%
EXCHANGE TRADED CONCEPTS, LLC 52,334$959,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders